Clayton L Schiltz, DO
Dermatology · Gilroy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 9 carriers
- Office
- 1
Offices
1 location
Plans that list them
32 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Schiltz’s office at (408) 713-2600 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$438,627
Medicare paid this office $438,627 for 794 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 636 | $100,413 | $87 |
| Destruction of precancer skin growth, 1 growth | 466 | $47,611 | $59 |
| Destruction of skin growth, 1-14 growths | 201 | $29,790 | $115 |
| Destruction of precancer skin growth, 15 or more growths | 89 | $27,698 | $175 |
| Destruction of precancer skin growth, 2-14 growths | 404 | $26,984 | $7 |
See all 14 services
| Short return visit (20+ min) | 636 | $100,413 | $87 |
| Destruction of precancer skin growth, 1 growth | 466 | $47,611 | $59 |
| Destruction of skin growth, 1-14 growths | 201 | $29,790 | $115 |
| Destruction of precancer skin growth, 15 or more growths | 89 | $27,698 | $175 |
| Destruction of precancer skin growth, 2-14 growths | 404 | $26,984 | $7 |
| New patient visit (30+ min) | 193 | $20,287 | $105 |
| Biopsy of related skin growth, first growth | 110 | $13,256 | $98 |
| Short return visit | 88 | $5,989 | $56 |
| Simple or single drainage of skin abscess | 20 | $3,422 | $137 |
| Return visit (30+ min) | 24 | $2,987 | $111 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 15 | $2,807 | $187 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 12 | $2,518 | $168 |
| New patient visit (45+ min) | 11 | $1,852 | $168 |
| Biopsy of related skin growth, each additional growth | 12 | $767 | $55 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 16 | More than 71% of doctors who do this |
| Removal of skin lesions | 2315 | More than 98% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 177 | More than 83% of doctors who do this |
Who their Medicare patients are
794 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 11% · Women 54% · Also on Medicaid 14% · Health risk score 1.03. Above the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 74% · Coronary heart disease 29% · Diabetes 26% · Chronic kidney disease 16% · Depression 16% · Atrial fibrillation 15% · Cancer 13% · Heart failure 12% · COPD 12% · Stroke 6% · Dementia 5%.
The office billed $751,242, Medicare allowed $565,854 and paid $438,627; for 9,323 services of 53 kinds; $130,419 of it was for drugs given in the office and $308,208 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 794 | 9,323 | 74 | 1.03 | $751,242 | $438,627 |
| 2023 | 737 | 8,890 | 74 | 0.98 | $791,336 | $467,182 |
| 2022 | 688 | 7,300 | 74 | 0.99 | $546,087 | $271,988 |
| 2021 | 595 | 8,105 | 74 | 1.04 | $495,676 | $253,759 |
| 2020 | 541 | 12,462 | 74 | 1.02 | $460,862 | $212,686 |
| 2019 | 578 | 7,247 | 73 | 1.04 | $498,650 | $233,571 |
| 2018 | 436 | 3,951 | 74 | 1.12 | $370,232 | $174,845 |
| 2017 | 373 | 3,181 | 73 | 1.17 | $301,690 | $138,331 |
| 2016 | 255 | 2,126 | 74 | 1.18 | $217,475 | $100,314 |
| 2015 | 116 | 730 | 72 | 1.22 | $91,705 | $42,751 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Short return visit (20+ min) | 553 | $76,723 | $80 |
| Destruction of precancer skin growth, 1 growth | 437 | $39,097 | $54 |
| Destruction of skin growth, 1-14 growths | 211 | $31,554 | $112 |
| Destruction of precancer skin growth, 15 or more growths | 82 | $25,342 | $172 |
| Destruction of precancer skin growth, 2-14 growths | 354 | $21,475 | $7 |
| New patient visit (30+ min) | 155 | $15,019 | $97 |
| Biopsy of related skin growth, first growth | 115 | $12,765 | $95 |
| Short return visit | 171 | $11,113 | $53 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 21 | $4,207 | $162 |
| Simple or single drainage of skin abscess | 30 | $4,039 | $115 |
| Return visit (30+ min) | 27 | $3,878 | $118 |
| New patient visit (15+ min) | 21 | $1,382 | $66 |
| Biopsy of ear | 12 | $1,219 | $87 |
2022: 13 services
| Short return visit (20+ min) | 510 | $73,981 | $83 |
| Destruction of skin growth, 1-14 growths | 282 | $41,916 | $113 |
| Destruction of precancer skin growth, 1 growth | 424 | $34,565 | $51 |
| Destruction of precancer skin growth, 15 or more growths | 87 | $26,749 | $175 |
| Destruction of precancer skin growth, 2-14 growths | 358 | $21,204 | $7 |
| New patient visit (30+ min) | 190 | $17,985 | $95 |
| Biopsy of related skin growth, first growth | 101 | $10,861 | $91 |
| Short return visit | 106 | $6,518 | $52 |
| Return visit (30+ min) | 25 | $3,678 | $115 |
| Simple or single drainage of skin abscess | 22 | $3,290 | $127 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 13 | $2,243 | $160 |
| New patient visit (15+ min) | 14 | $869 | $62 |
| Biopsy of related skin growth, each additional growth | 11 | $637 | $53 |
2021: 16 services
| Short return visit (20+ min) | 459 | $72,323 | $84 |
| Destruction of precancer skin growth, 1 growth | 349 | $32,924 | $54 |
| Destruction of skin growth, 1-14 growths | 173 | $26,475 | $116 |
| Destruction of precancer skin growth, 15 or more growths | 86 | $26,397 | $168 |
| Destruction of precancer skin growth, 2-14 growths | 308 | $18,103 | $7 |
| New patient visit (30+ min) | 167 | $15,788 | $95 |
| Biopsy of related skin growth, first growth | 93 | $10,701 | $101 |
| Short return visit | 101 | $7,007 | $55 |
| Application of light with debridement to destroy precancer skin growth | 13 | $4,527 | $283 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 13 | $3,845 | None |
| Simple or single drainage of skin abscess | 24 | $3,540 | $122 |
| Return visit (30+ min) | 24 | $3,515 | $121 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 14 | $2,163 | $155 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 11 | $2,160 | $180 |
| New patient visit (15+ min) | 13 | $879 | $68 |
| Biopsy of related skin growth, each additional growth | 12 | $752 | $54 |
2020: 15 services
| Short return visit (20+ min) | 385 | $45,549 | $64 |
| Destruction of precancer skin growth, 1 growth | 321 | $26,686 | $51 |
| Destruction of skin growth, 1-14 growths | 148 | $22,440 | $112 |
| Destruction of precancer skin growth, 15 or more growths | 70 | $16,717 | $159 |
| Return visit (30+ min) | 126 | $14,841 | $102 |
| Destruction of precancer skin growth, 2-14 growths | 280 | $14,439 | $6 |
| Application of light with debridement to destroy precancer skin growth | 29 | $10,286 | $251 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 29 | $9,335 | None |
| Biopsy of related skin growth, first growth | 81 | $8,484 | $90 |
| New patient visit (30+ min) | 79 | $7,127 | $90 |
| New patient visit (15+ min) | 80 | $4,909 | $61 |
| Simple or single drainage of skin abscess | 19 | $2,852 | $124 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 11 | $2,004 | $154 |
| Biopsy of related skin growth, each additional growth | 15 | $962 | $53 |
| Short return visit | 17 | $407 | $24 |
2019: 11 services
| Short return visit (20+ min) | 419 | $54,657 | $65 |
| Destruction of precancer skin growth, 1 growth | 309 | $28,011 | $50 |
| Destruction of skin growth, 1-14 growths | 157 | $23,881 | $106 |
| Destruction of precancer skin growth, 15 or more growths | 81 | $21,110 | $147 |
| Destruction of precancer skin growth, 2-14 growths | 280 | $14,519 | $6 |
| Biopsy of related skin growth, first growth | 140 | $12,770 | $86 |
| Return visit (30+ min) | 112 | $11,374 | $93 |
| New patient visit (30+ min) | 112 | $10,220 | $91 |
| New patient visit (15+ min) | 129 | $7,935 | $62 |
| Simple or single drainage of skin abscess | 29 | $3,575 | $115 |
| Short return visit | 54 | $2,577 | $40 |
2018: 13 services
| Short return visit (20+ min) | 319 | $41,929 | $63 |
| Destruction of precancer skin growth, 15 or more growths | 76 | $19,888 | $133 |
| Destruction of precancer skin growth, 1 growth | 237 | $19,362 | $50 |
| Destruction of skin growth, 1-14 growths | 102 | $17,281 | $107 |
| Return visit (30+ min) | 89 | $10,615 | $92 |
| Biopsy of single growth of skin and/or tissue | 95 | $9,954 | $91 |
| Destruction of precancer skin growth, 2-14 growths | 214 | $9,640 | $5 |
| New patient visit (30+ min) | 75 | $6,631 | $88 |
| New patient visit (15+ min) | 100 | $6,488 | $65 |
| Simple or single drainage of skin abscess | 28 | $4,054 | $107 |
| Short return visit | 54 | $2,686 | $40 |
| Biopsy of ear | 12 | $933 | $78 |
| Biopsy of each additional growth of skin and/or tissue | 12 | $461 | $31 |
2017: 14 services
| Short return visit (20+ min) | 240 | $28,541 | $62 |
| Destruction of precancer skin growth, 1 growth | 191 | $17,295 | $48 |
| Destruction of skin growth, 1-14 growths | 87 | $13,337 | $104 |
| Destruction of precancer skin growth, 15 or more growths | 56 | $12,985 | $137 |
| Biopsy of single growth of skin and/or tissue | 103 | $10,736 | $87 |
| Return visit (30+ min) | 77 | $9,475 | $95 |
| New patient visit (30+ min) | 98 | $8,040 | $82 |
| Destruction of precancer skin growth, 2-14 growths | 175 | $7,598 | $5 |
| New patient visit (15+ min) | 114 | $6,795 | $60 |
| Simple or single drainage of skin abscess | 30 | $4,179 | $110 |
| Short return visit | 75 | $3,381 | $37 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 11 | $1,806 | $164 |
| Biopsy of ear | 12 | $1,005 | $84 |
| Biopsy of each additional growth of skin and/or tissue | 13 | $399 | $31 |
2016: 13 services
| Short return visit (20+ min) | 157 | $22,150 | $65 |
| Destruction of precancer skin growth, 1 growth | 118 | $10,734 | $49 |
| New patient visit (30+ min) | 119 | $8,945 | $75 |
| Destruction of skin growth, 1-14 growths | 59 | $8,902 | $102 |
| Biopsy of single growth of skin and/or tissue | 76 | $7,926 | $86 |
| Return visit (30+ min) | 57 | $6,808 | $92 |
| Destruction of precancer skin growth, 15 or more growths | 22 | $6,402 | $146 |
| Destruction of precancer skin growth, 2-14 growths | 97 | $4,831 | $5 |
| New patient visit (15+ min) | 76 | $4,553 | $60 |
| Simple or single drainage of skin abscess | 18 | $3,158 | $109 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 11 | $1,606 | $146 |
| Short return visit | 32 | $1,539 | $40 |
| Biopsy of each additional growth of skin and/or tissue | 14 | $429 | $31 |
2015: 9 services
| New patient visit (30+ min) | 76 | $7,358 | $97 |
| Short return visit (20+ min) | 49 | $6,964 | $68 |
| Biopsy of single growth of skin and/or tissue | 38 | $3,891 | $95 |
| Return visit (30+ min) | 28 | $3,859 | $99 |
| Destruction of precancer skin growth, 1 growth | 47 | $3,780 | $54 |
| Destruction of skin growth, 1-14 growths | 25 | $3,440 | $111 |
| Destruction of precancer skin growth, 15 or more growths | 18 | $3,066 | $146 |
| New patient visit (15+ min) | 38 | $2,545 | $67 |
| Destruction of precancer skin growth, 2-14 growths | 42 | $1,456 | $6 |
Medicaid work
$2,955 in 2024
Medicaid paid $2,955 for 321 billed services this clinician did in 2024, up to 40 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 274 | $2,534 |
| New patient visit (30+ min) | 47 | $421 |
| 2024 | 321 | 2 | 40 | $2,955 |
| 2023 | 590 | 3 | 47 | $5,593 |
| 2022 | 525 | 4 | 55 | $3,975 |
| 2021 | 682 | 3 | 48 | $4,432 |
| 2020 | 514 | 2 | 46 | $3,280 |
| 2019 | 446 | 2 | 47 | $4,117 |
| 2018 | 233 | 1 | 25 | $1,878 |
See the largest Medicaid services in earlier years
2023
| New patient visit (30+ min) | 148 | $3,041 |
| Short return visit (20+ min) | 430 | $2,399 |
| Return visit (30+ min) | 12 | $153 |
2022
| Short return visit (20+ min) | 397 | $2,152 |
| New patient visit (30+ min) | 104 | $1,583 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 12 | $200 |
| Return visit (30+ min) | 12 | $41 |
2021
| Short return visit (20+ min) | 458 | $2,240 |
| New patient visit (30+ min) | 198 | $1,593 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 26 | $599 |
2020
| Short return visit (20+ min) | 370 | $2,269 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 144 | $1,010 |
2019
| Short return visit (20+ min) | 344 | $2,652 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 102 | $1,466 |
2018
| Short return visit (20+ min) | 233 | $1,878 |
Drugs they prescribed that Part D paid
$517,686
Pharmacies billed $517,686 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
796 generic and 99 brand-name prescriptions · $517,686 in drug cost · 89 antibiotic prescriptions to 46 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Skyrizi | 12 | $240,025 | $20,002 |
| Dupixent | 20 | $84,619 | $4,231 |
| Opzelura | 16 | $30,938 | $1,934 |
| Jublia | 14 | $9,941 | $710 |
| Betamethasone Dipropionate | 106 | $4,495 | $42 |
See all 20 drugs
| Skyrizi | 12 | $240,025 | $20,002 |
| Dupixent | 20 | $84,619 | $4,231 |
| Opzelura | 16 | $30,938 | $1,934 |
| Jublia | 14 | $9,941 | $710 |
| Betamethasone Dipropionate | 106 | $4,495 | $42 |
| Metronidazole | 31 | $2,801 | $90 |
| Fluocinonide | 36 | $2,348 | $65 |
| Fluorouracil | 38 | $2,317 | $61 |
| Triamcinolone Acetonide | 207 | $1,855 | $9 |
| Ketoconazole | 56 | $1,485 | $27 |
| Clindamycin Phosphate | 34 | $1,134 | $33 |
| Mometasone Furoate | 28 | $489 | $17 |
| Doxycycline Monohydrate | 29 | $471 | $16 |
| Valacyclovir | 12 | $276 | $23 |
| Cephalexin | 34 | $272 | $8 |
| Nystatin | 15 | $223 | $15 |
| Doxycycline Hyclate | 16 | $188 | $12 |
| Mupirocin | 27 | $183 | $7 |
| Minoxidil | 14 | $158 | $11 |
| Prednisone | 31 | $132 | $4 |
Year by year
| 2024 | 895 | 350 | None | 11% | $517,686 |
| 2023 | 651 | 284 | None | 12% | $514,008 |
| 2022 | 619 | 248 | None | 9% | $420,058 |
| 2021 | 678 | 263 | None | 9% | $177,975 |
| 2020 | 523 | 220 | 0% (0) | 14% | $142,275 |
| 2019 | 525 | 202 | 0% (0) | 17% | $183,764 |
| 2018 | 485 | 180 | 0% (0) | 18% | $119,192 |
| 2017 | 460 | 172 | None | 10% | $23,267 |
| 2016 | 350 | 136 | 0% (0) | 9% | $19,798 |
| 2015 | 153 | 66 | None | 19% | $13,240 |
| 2014 | 118 | 67 | 0% (0) | 14% | $8,083 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Skyrizi | 15 | $323,492 | $21,566 |
| Dupixent | 14 | $56,362 | $4,026 |
| Opzelura | 11 | $22,003 | $2,000 |
| Jublia | 12 | $10,009 | $834 |
| Fluorouracil | 33 | $3,929 | $119 |
| Betamethasone Dipropionate | 61 | $3,504 | $57 |
| Fluocinonide | 40 | $3,474 | $87 |
| Clindamycin Phosphate | 40 | $1,939 | $48 |
| Metronidazole | 16 | $1,795 | $112 |
| Triamcinolone Acetonide | 139 | $1,266 | $9 |
| Ketoconazole | 33 | $1,045 | $32 |
| Doxycycline Monohydrate | 20 | $1,009 | $50 |
| Mometasone Furoate | 23 | $863 | $38 |
| Cephalexin | 34 | $737 | $22 |
| Mupirocin | 24 | $367 | $15 |
| Nystatin | 18 | $295 | $16 |
| Prednisone | 24 | $84 | $3 |
2022: 15 drugs
| Skyrizi | 13 | $253,804 | $19,523 |
| Otezla | 12 | $52,591 | $4,383 |
| Fluocinonide | 63 | $5,365 | $85 |
| Fluorouracil | 37 | $4,716 | $127 |
| Betamethasone Dipropionate | 65 | $3,782 | $58 |
| Clindamycin Phosphate | 40 | $2,634 | $66 |
| Metronidazole | 19 | $2,168 | $114 |
| Mometasone Furoate | 34 | $1,163 | $34 |
| Triamcinolone Acetonide | 127 | $1,000 | $8 |
| Doxycycline Monohydrate | 18 | $915 | $51 |
| Ketoconazole | 22 | $799 | $36 |
| Doxycycline Hyclate | 14 | $600 | $43 |
| Mupirocin | 18 | $139 | $8 |
| Prednisone | 24 | $133 | $6 |
| Cephalexin | 18 | $62 | $3 |
2021: 16 drugs
| Otezla | 19 | $76,678 | $4,036 |
| Fluocinonide | 81 | $9,177 | $113 |
| Betamethasone Dipropionate | 61 | $3,744 | $61 |
| Metronidazole | 31 | $3,334 | $108 |
| Fluorouracil | 20 | $1,602 | $80 |
| Clobetasol Propionate | 14 | $1,545 | $110 |
| Clindamycin Phosphate | 27 | $1,503 | $56 |
| Triamcinolone Acetonide | 182 | $1,403 | $8 |
| Mometasone Furoate | 35 | $1,091 | $31 |
| Doxycycline Hyclate | 12 | $749 | $62 |
| Ketoconazole | 18 | $583 | $32 |
| Econazole Nitrate | 14 | $525 | $37 |
| Doxycycline Monohydrate | 13 | $361 | $28 |
| Mupirocin | 21 | $209 | $10 |
| Cephalexin | 25 | $106 | $4 |
| Prednisone | 18 | $63 | $3 |
2020: 11 drugs
| Otezla | 29 | $101,320 | $3,494 |
| Metronidazole | 25 | $3,382 | $135 |
| Fluocinonide | 43 | $3,123 | $73 |
| Betamethasone Dipropionate | 50 | $2,975 | $60 |
| Clindamycin Phosphate | 23 | $1,845 | $80 |
| Triamcinolone Acetonide | 146 | $1,219 | $8 |
| Mometasone Furoate | 25 | $784 | $31 |
| Prednisone | 19 | $659 | $35 |
| Ketoconazole | 14 | $559 | $40 |
| Nystatin | 11 | $174 | $16 |
| Cephalexin | 15 | $48 | $3 |
2019: 15 drugs
| Otezla | 22 | $76,317 | $3,469 |
| Humira(Cf) | 11 | $60,793 | $5,527 |
| Fluocinonide | 47 | $3,961 | $84 |
| Metronidazole | 20 | $2,856 | $143 |
| Clindamycin Phosphate | 34 | $2,577 | $76 |
| Clobetasol Propionate | 17 | $2,461 | $145 |
| Betamethasone Dipropionate | 29 | $2,144 | $74 |
| Triamcinolone Acetonide | 128 | $998 | $8 |
| Mometasone Furoate | 34 | $967 | $28 |
| Econazole Nitrate | 12 | $588 | $49 |
| Prednisone | 19 | $584 | $31 |
| Doxycycline Hyclate | 13 | $434 | $33 |
| Ketoconazole | 14 | $234 | $17 |
| Mupirocin | 13 | $98 | $8 |
| Cephalexin | 14 | $70 | $5 |
2018: 12 drugs
| Finacea | 12 | $4,379 | $365 |
| Metronidazole | 23 | $3,425 | $149 |
| Clindamycin Phosphate | 32 | $2,581 | $81 |
| Fluocinonide | 25 | $1,856 | $74 |
| Econazole Nitrate | 17 | $1,513 | $89 |
| Betamethasone Dipropionate | 23 | $1,506 | $65 |
| Doxycycline Hyclate | 33 | $1,224 | $37 |
| Triamcinolone Acetonide | 130 | $1,071 | $8 |
| Ketoconazole | 25 | $837 | $33 |
| Clobetasol Propionate | 12 | $745 | $62 |
| Mometasone Furoate | 18 | $506 | $28 |
| Cephalexin | 22 | $89 | $4 |
2017: 13 drugs
| Clindamycin Phosphate | 31 | $2,334 | $75 |
| Metronidazole | 16 | $2,258 | $141 |
| Ketoconazole | 62 | $2,101 | $34 |
| Econazole Nitrate | 13 | $1,738 | $134 |
| Clobetasol Propionate | 11 | $1,327 | $121 |
| Fluorouracil | 11 | $1,308 | $119 |
| Betamethasone Dipropionate | 17 | $1,303 | $77 |
| Doxycycline Hyclate | 22 | $1,041 | $47 |
| Mometasone Furoate | 33 | $1,013 | $31 |
| Desoximetasone | 13 | $1,010 | $78 |
| Triamcinolone Acetonide | 132 | $977 | $7 |
| Nystatin | 17 | $264 | $16 |
| Cephalexin | 20 | $117 | $6 |
2016: 10 drugs
| Clobetasol Propionate | 11 | $1,896 | $172 |
| Ketoconazole | 48 | $1,807 | $38 |
| Metronidazole | 12 | $1,797 | $150 |
| Econazole Nitrate | 19 | $1,546 | $81 |
| Fluocinolone Acetonide | 12 | $1,439 | $120 |
| Clindamycin Phosphate | 22 | $1,405 | $64 |
| Doxycycline Hyclate | 17 | $1,020 | $60 |
| Triamcinolone Acetonide | 106 | $789 | $7 |
| Mometasone Furoate | 17 | $489 | $29 |
| Cephalexin | 15 | $71 | $5 |
2015: 4 drugs
| Econazole Nitrate | 11 | $1,900 | $173 |
| Fluocinolone Acetonide | 12 | $1,797 | $150 |
| Ketoconazole | 12 | $334 | $28 |
| Triamcinolone Acetonide | 23 | $181 | $8 |
2014: 3 drugs
| Fluocinolone Acetonide | 11 | $1,167 | $106 |
| Ammonium Lactate | 16 | $396 | $25 |
| Triamcinolone Acetonide | 21 | $160 | $8 |
Money from drug and device companies
$2,482 in 2025
| 2025 | 16 | 107 | None | $2,482 |
| 2024 | 15 | 87 | None | $1,692 |
| 2023 | 15 | 98 | None | $2,093 |
| 2022 | 13 | 58 | None | $1,437 |
| 2021 | 15 | 46 | None | $858 |
| 2020 | 16 | 43 | None | $699 |
| 2019 | 10 | 40 | $350 | $1,145 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $431 | 18 payments
|
| Regeneron Healthcare Solutions | Dupixent | $379 | 13 payments
|
| Janssen Biotech | Tremfya | $310 | 10 payments
|
| Arcutis Biotherapeutics | Zoryve | $248 | 16 payments
|
| Ucb | Bimzelx | $196 | 13 payments
|
| Galderma Laboratories L.P. | Nemluvio | $180 | 3 payments
|
See all 107 published payments
| Abbvie | Meals · 2025-12-22 | Rinvoq | $12 |
| Janssen Biotech | Meals · 2025-12-11 | Tremfya | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-12-11 | Dupixent | $9 |
| Arcutis Biotherapeutics | Meals · 2025-12-11 | Zoryve | $24 |
| Incyte | Meals · 2025-12-02 | Opzelura | $16 |
| Genzyme | Meals · 2025-12-01 | Dupixent | $37 |
| Regeneron Healthcare Solutions | Meals · 2025-11-25 | Dupixent | $24 |
| Janssen Biotech | Education · 2025-11-19 | Tremfya | $95 |
| Galderma Laboratories L.P. | Meals · 2025-11-19 | Nemluvio | $128 |
| LEO Pharma | Meals · 2025-11-12 | Anzupgo | $26 |
| Arcutis Biotherapeutics | Meals · 2025-11-12 | Zoryve | $16 |
| Novartis Pharmaceuticals | Meals · 2025-11-03 | Cosentyx | $23 |
| Abbvie | Meals · 2025-10-30 | Rinvoq | $16 |
| Regeneron Healthcare Solutions | Meals · 2025-10-30 | Dupixent | $14 |
| Incyte | Meals · 2025-10-30 | Opzelura | $12 |
| Pfizer | Meals · 2025-10-30 | Cibinqo | $21 |
| Abbvie | Meals · 2025-10-24 | Skyrizi | $31 |
| Abbvie | Meals · 2025-10-22 | Rinvoq | $32 |
| Arcutis Biotherapeutics | Meals · 2025-10-21 | Zoryve | $25 |
| Ucb | Meals · 2025-10-20 | Bimzelx | $14 |
| Abbvie | Meals · 2025-10-13 | Rinvoq | $9 |
| Genzyme | Meals · 2025-10-08 | Dupixent | $29 |
| Sun Pharmaceutical Industries | Meals · 2025-10-06 | Ilumya | $29 |
| Arcutis Biotherapeutics | Meals · 2025-10-01 | Zoryve | $10 |
| Ucb | Meals · 2025-09-24 | Bimzelx | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-09-19 | Dupixent | $30 |
| Abbvie | Meals · 2025-09-16 | Rinvoq | $29 |
| Incyte | Meals · 2025-09-16 | Opzelura | $14 |
| Ucb | Meals · 2025-09-09 | Bimzelx | $18 |
| Arcutis Biotherapeutics | Meals · 2025-09-02 | Zoryve | $24 |
| Incyte | Meals · 2025-08-28 | Opzelura | $28 |
| Regeneron Healthcare Solutions | Education · 2025-08-21 | Dupixent | $95 |
| Arcutis Biotherapeutics | Meals · 2025-08-20 | Zoryve | $29 |
| Abbvie | Meals · 2025-08-19 | Rinvoq | $12 |
| Ucb | Meals · 2025-08-19 | Bimzelx | $12 |
| Incyte | Meals · 2025-08-19 | Opzelura | $16 |
| Abbvie | Meals · 2025-08-14 | Rinvoq | $34 |
| Novartis Pharmaceuticals | Meals · 2025-08-07 | Cosentyx | $16 |
| Janssen Biotech | Meals · 2025-08-01 | Tremfya | $31 |
| Arcutis Biotherapeutics | Meals · 2025-07-30 | Zoryve | $9 |
| Pfizer | Meals · 2025-07-29 | Cibinqo | $29 |
| Abbvie | Meals · 2025-07-24 | Rinvoq | $33 |
| Arcutis Biotherapeutics | Meals · 2025-07-23 | Zoryve | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-07-22 | Dupixent | $6 |
| Galderma Laboratories L.P. | Meals · 2025-07-22 | Nemluvio | $26 |
| Abbvie | Meals · 2025-07-18 | Rinvoq | $23 |
| Arcutis Biotherapeutics | Meals · 2025-07-14 | Zoryve | $23 |
| Abbvie | Meals · 2025-06-26 | Rinvoq | $22 |
| Janssen Biotech | Meals · 2025-06-18 | Tremfya | $13 |
| Novartis Pharmaceuticals | Meals · 2025-06-17 | Cosentyx | $14 |
| Ucb | Meals · 2025-06-17 | Bimzelx | $14 |
| Galderma Laboratories L.P. | Meals · 2025-06-16 | None | $26 |
| Arcutis Biotherapeutics | Meals · 2025-06-10 | Zoryve | $14 |
| Abbvie | Meals · 2025-06-05 | Rinvoq | $33 |
| Incyte | Meals · 2025-05-30 | Opzelura | $15 |
| Abbvie | Meals · 2025-05-27 | Rinvoq | $6 |
| Genzyme | Meals · 2025-05-19 | Dupixent | $36 |
| Regeneron Healthcare Solutions | Meals · 2025-05-14 | Dupixent | $8 |
| Arcutis Biotherapeutics | Meals · 2025-05-14 | Zoryve | $9 |
| Janssen Biotech | Meals · 2025-05-13 | Tremfya | $30 |
| Abbvie | Meals · 2025-05-13 | Skyrizi | $24 |
| Ucb | Meals · 2025-05-13 | Bimzelx | $14 |
| Biofrontera | Meals · 2025-05-07 | None | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-05-02 | Dupixent | $117 |
| Incyte | Meals · 2025-05-02 | Opzelura | $8 |
| Novartis Pharmaceuticals | Meals · 2025-05-01 | Cosentyx | $16 |
| Ucb | Meals · 2025-04-29 | Bimzelx | $15 |
| STRATA Skin Sciences | Meals · 2025-04-28 | Xtrac | $27 |
| Abbvie | Meals · 2025-04-17 | Rinvoq | $32 |
| Regeneron Healthcare Solutions | Meals · 2025-04-15 | Dupixent | $18 |
| Ucb | Meals · 2025-04-15 | Bimzelx | $13 |
| Arcutis Biotherapeutics | Meals · 2025-04-15 | Zoryve | $21 |
| Janssen Biotech | Meals · 2025-04-10 | Tremfya | $17 |
| Incyte | Meals · 2025-04-08 | Opzelura | $28 |
| Ucb | Meals · 2025-04-01 | Bimzelx | $14 |
| Genzyme | Meals · 2025-04-01 | Dupixent | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-03-27 | Dupixent | $10 |
| Abbvie | Meals · 2025-03-25 | Skyrizi | $22 |
| Genzyme | Education · 2025-03-25 | Dupixent | $8 |
| Janssen Biotech | Meals · 2025-03-24 | Tremfya | $18 |
| Ucb | Meals · 2025-03-21 | Bimzelx | $33 |
| Incyte | Meals · 2025-03-20 | Opzelura | $15 |
| Abbvie | Meals · 2025-03-13 | Rinvoq | $32 |
| Incyte | Meals · 2025-03-13 | Opzelura | $14 |
| Amgen | Meals · 2025-03-13 | Otezla | $24 |
| Ucb | Meals · 2025-03-11 | Bimzelx | $13 |
| Arcutis Biotherapeutics | Meals · 2025-03-11 | Zoryve | $9 |
| Arcutis Biotherapeutics | Meals · 2025-03-11 | Zoryve | $7 |
| Janssen Biotech | Meals · 2025-03-10 | Tremfya | $17 |
| Genzyme | Meals · 2025-03-10 | Dupixent | $34 |
| STRATA Skin Sciences | Meals · 2025-03-03 | Xtrac | $19 |
| STRATA Skin Sciences | Meals · 2025-03-03 | Xtrac | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-02-27 | Dupixent | $15 |
| Janssen Biotech | Meals · 2025-02-26 | Tremfya | $37 |
| Janssen Biotech | Meals · 2025-02-12 | Tremfya | $23 |
| Arcutis Biotherapeutics | Meals · 2025-02-12 | Zoryve | $9 |
| Ucb | Meals · 2025-02-11 | Bimzelx | $13 |
| Merz North America | Meals · 2025-02-06 | Xeomin | $30 |
| Pfizer | Meals · 2025-02-03 | Cibinqo | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-01-29 | Libtayo | $28 |
| Abbvie | Meals · 2025-01-24 | Skyrizi | $29 |
| Ucb | Meals · 2025-01-22 | Bimzelx | $17 |
| Incyte | Meals · 2025-01-22 | Opzelura | $11 |
| Pfizer | Meals · 2025-01-22 | Eucrisa | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-01-21 | Dupixent | $7 |
| Arcutis Biotherapeutics | Meals · 2025-01-08 | Zoryve | $10 |
| STRATA Skin Sciences | Meals · 2025-01-03 | Xtrac | $27 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,692
| Abbvie | Rinvoq | $344 | 17 payments
|
| Janssen Biotech | Tremfya | $275 | 15 payments
|
| Incyte | Opzelura | $231 | 15 payments
|
| Sun Pharmaceutical Industries | Ilumya | $213 | 9 payments
|
| Genzyme | Dupixent | $175 | 8 payments
|
| Arcutis Biotherapeutics | Zoryve | $144 | 8 payments
|
| Lilly USA | Taltz | $91 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $45 | 2 payments
|
| Galderma Laboratories L.P. | None | $39 | 2 payments
|
| Pfizer | Eucrisa | $30 | 2 payments
|
| LEO Pharma | Adbry | $28 | 1 payment
|
| Amgen | Otezla | $26 | 1 payment
|
| Biofrontera | Ameluz | $22 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $14 | 1 payment
|
| Dermavant Sciences | Vtama | $14 | 1 payment
|
2023: $2,093
| Incyte | Opzelura | $365 | 17 payments
|
| Janssen Biotech | Tremfya | $341 | 19 payments
|
| Regeneron Healthcare Solutions | Dupixent | $198 | 10 payments
|
| AbbVie | Skyrizi | $189 | 9 payments
|
| Genzyme | Dupixent | $169 | 9 payments
|
| Dermavant Sciences | Vtama | $168 | 9 payments
|
| Sun Pharmaceutical Industries | Winlevi | $160 | 7 payments
|
| LEO Pharma | Adbry | $145 | 6 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $123 | 1 payment
|
| Amgen | Otezla | $79 | 3 payments
|
| Arcutis Biotherapeutics | None | $60 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $42 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $20 | 1 payment
|
| Journey Medical | None | $19 | 1 payment
|
| Biofrontera | Ameluz | $16 | 1 payment
|
2022: $1,437
| Regeneron Healthcare Solutions | Dupixent | $386 | 10 payments
|
| Sun Pharmaceutical Industries | Ilumya | $213 | 6 payments
|
| Abbvie | Skyrizi | $170 | 8 payments
|
| Janssen Biotech | Tremfya | $136 | 11 payments
|
| LEO Pharma | Adbry | $135 | 8 payments
|
| Sanofi-Aventis U.S. | Dupixent | $99 | 1 payment
|
| Genzyme | Dupixent | $72 | 3 payments
|
| Galderma Laboratories L.P. | Twyneo | $63 | 3 payments
|
| Incyte | Opzelura | $52 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $50 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $23 | 1 payment
|
| iCAD | Axxent Surface Controller | $20 | 1 payment
|
| Journey Medical | Qbrexza | $19 | 1 payment
|
2021: $858
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $124 | 9 payments
|
| Pfizer | Eucrisa | $116 | 5 payments
|
| Galderma Laboratories L.P. | Aklief | $97 | 5 payments
|
| Janssen Biotech | Remicade | $74 | 4 payments
|
| AbbVie | Skyrizi | $64 | 3 payments
|
| Genzyme | Dupixent | $61 | 3 payments
|
| Amgen | Otezla | $57 | 3 payments
|
| LEO Pharma | Enstilar | $56 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $40 | 2 payments
|
| VYNE Pharmaceuticals | Zilxi | $38 | 2 payments
|
| Dermira | Qbrexza | $37 | 2 payments
|
| Sun Pharmaceutical Industries | Absorica Ld | $37 | 2 payments
|
| Incyte | Opzelura | $22 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $18 | 1 payment
|
| Almirall | Seysara | $17 | 1 payment
|
2020: $699
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $142 | 11 payments
|
| Pfizer | Eucrisa | $117 | 5 payments
|
| AbbVie | Skyrizi | $55 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $47 | 3 payments
|
| Galderma Laboratories L.P. | Soolantra | $44 | 3 payments
|
| Genzyme | Dupixent | $42 | 2 payments
|
| Biofrontera | Ameluz | $41 | 4 payments
|
| VYNE Pharmaceuticals | Amzeeq | $38 | 2 payments
|
| Mayne Pharma | Doryx | $37 | 2 payments
|
| Amgen | Otezla | $30 | 2 payments
|
| LEO Pharma | Finacea | $25 | 1 payment
|
| Dermira | Qbrexza | $21 | 1 payment
|
| Janssen Biotech | Remicade | $16 | 1 payment
|
| Ucb | Cimzia | $16 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $16 | 1 payment
|
| Almirall | Seysara | $12 | 1 payment
|
2019: $1,145
| Biofrontera | Ameluz | $527 | 7 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $165 | 6 payments
|
| Novartis Pharmaceuticals | Cosentyx | $130 | 3 payments
|
| Celgene | Otezla | $124 | 12 payments
|
| AbbVie | Humira | $54 | 3 payments
|
| Pfizer | Eucrisa | $49 | 3 payments
|
| Ucb | Cimzia | $49 | 3 payments
|
| Mayne Pharma | Doryx | $20 | 1 payment
|
| Galderma Laboratories L.P. | Epiduo Forte | $15 | 1 payment
|
| LEO Pharma | Enstilar | $14 | 1 payment
|
Checkups this office reported
5 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 97.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 100%That's most of the people this applied to. | 1,037 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 39%That's less than half. | 1,134 |
| Melanoma: Continuity of Care - Recall SystemAs Medicare defines this measure | 100% | 86 |
| Psoriasis: Clinical Response to Systemic MedicationsAs Medicare defines this measure | 0% | 33 |
| Tobacco Use and Help with Quitting Among AdolescentsAs Medicare defines this measure | 100% | 246 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Drug Cost Transparency
Professional record
- NPI
- 1003135823
- Licence
- CA 20A13538
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 7888 Wren Ave Ste A110, Gilroy, CA, 95020
- NPI first listed
- 2010-05-18
- NPI last updated
- 2018-01-18
This is when the NPI record was last certified, not a medical board exam.